Company intelligence / Profile preview

Enlitic

San Francisco, California, United Statesenlitic.com ↗

Ownership: Private
Development stage: Commercial

Overview

Enlitic’s AI-driven solutions have demonstrated the ability to speed up radiologist interpretation by over 20%, improve true positive rates, reduce false positives by over 10%, and assist in identifying malignancies up to two years earlier than traditional methods. The company’s platforms are used for standardizing, protecting, integrating, and analyzing medical imaging data to optimize clinical workflows and support real-world evidence generation.

Modalities: Device (AI-driven data platform for medical imaging)
Industry: Medical Imaging

Partnerships

MarubeniCapitol HealthBlackford Analysis partnership for distribution/integration of applications

Beyond the preview

Go deeper on Enlitic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enlitic.

Explore the full profile